Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Ca

Chemotherapy-Induced Neuropathy in Cancer Survivors

(2017) Christine Miaskowski et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)

(2017) Jacobien M. Kieffer et al.   QUALITY OF LIFE RESEARCH

Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey

(2017) J . Matt McCrary et al.   SUPPORTIVE CARE IN CANCER

Patient-reported (EORTC QLQ-CIPN20) versus physician-reported (CTCAE) quantification of oxaliplatin- and paclitaxel/carboplatin-induced peripheral neuropathy in NCCTG/Alliance clinical trials

(2017) Jennifer Le-Rademacher et al.   SUPPORTIVE CARE IN CANCER

The experience of chemotherapy-induced peripheral neuropathy in adult cancer patients: a qualitative thematic synthesis

(2016) M.A.L. Tanay et al.   EUROPEAN JOURNAL OF CANCER CARE

Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials

(2016) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Content validity of symptom-based measures for diabetic, chemotherapy, and HIV peripheral neuropathy

(2016) Jennifer S. Gewandter et al.   MUSCLE & NERVE

Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives

(2015) Marianne Ewertz et al.   ACTA ONCOLOGICA

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2014) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review

(2014) Floortje Mols et al.   SUPPORTIVE CARE IN CANCER

Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire

(2013) Ellen M. Lavoie Smith et al.   QUALITY OF LIFE RESEARCH

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

(2012) G. Cavaletti et al.   ANNALS OF ONCOLOGY

Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations

(2011) T. Luckett et al.   ANNALS OF ONCOLOGY

Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools

(2010) Guido Cavaletti et al.   EUROPEAN JOURNAL OF CANCER

Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties

(2010) Kathleen A. Griffith et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02

(2009) Kojiro Shimozuma et al.   SUPPORTIVE CARE IN CANCER